相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cellular FLIPL plays a survival role and regulates morphogenesis in breast epithelial cells
Rosario Yerbes et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
An Fcγ Receptor-Dependent Mechanism Drives Antibody-Mediated Target-Receptor Signaling in Cancer Cells
Nicholas S. Wilson et al.
CANCER CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Phase I and pharmacokinetic study of lexatumumab (HGS-ETR2) given every 2 weeks in patients with advanced solid tumors
H. A. Wakelee et al.
ANNALS OF ONCOLOGY (2010)
Phase 1b Study of Dulanermin (recombinant human Apo2L/TRAIL) in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Patients With Advanced Non-Squamous Non-Small-Cell Lung Cancer
Jean-Charles Soria et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Phase I Dose-Escalation Study of Recombinant Human Apo2L/TRAIL, a Dual Proapoptotic Receptor Agonist, in Patients With Advanced Cancer
Roy S. Herbst et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
New insights into apoptosis signaling by Apo2L/TRAIL
F. Gonzalvez et al.
ONCOGENE (2010)
Caveolin-1 negatively regulates TRAIL-induced apoptosis in human hepatocarcinoma cells
Xiangxuan Zhao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Palmitoylation of the TRAIL receptor DR4 confers an efficient TRAIL-induced cell death signalling
Aurelie Rossin et al.
BIOCHEMICAL JOURNAL (2009)
Cullin3-Based Polyubiquitination and p62-Dependent Aggregation of Caspase-8 Mediate Extrinsic Apoptosis Signaling
Zhaoyu Jin et al.
CELL (2009)
Mapatumumab, a Fully Human Agonistic Monoclonal Antibody That Targets TRAIL-R1, in Combination with Gemcitabine and Cisplatin: a Phase I Study
Constantijne H. Mom et al.
CLINICAL CANCER RESEARCH (2009)
TNF-related apoptosis-inducing ligand (TRAIL): A new path to anti-cancer therapies
Peter A. Holoch et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Mapatumumab, an Antibody Targeting TRAIL-R1, in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid Malignancies: Results of a Phase I and Pharmacokinetic Study
Stephen Leong et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Major Depressive Disorder in Long-Term Cancer Survivors: Analysis of the National Comorbidity Survey Replication
William F. Pirl et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Genes that mediate breast cancer metastasis to the brain
Paula D. Bos et al.
NATURE (2009)
Membrane-bound Fas ligand only is essential for Fas-induced apoptosis
Lorraine A. O' Reilly et al.
NATURE (2009)
APP binds DR6 to trigger axon pruning and neuron death via distinct caspases
Anatoly Nikolaev et al.
NATURE (2009)
Death receptor signal transducers: nodes of coordination in immune signaling networks
Nicholas S. Wilson et al.
NATURE IMMUNOLOGY (2009)
Apomab: An agonist monoclonal antibody directed against Death Receptor 5/TRAIL-Receptor 2 for use in the treatment of solid tumors
D. Ross Camidge
EXPERT OPINION ON BIOLOGICAL THERAPY (2008)
TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor development
Anne Grosse-Wilde et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Phase 2 study of mapatumumab, a fully human agonistic monoclonal antibody which targets and activates the TRAIL receptor-1, in patients with advanced non-small cell lung cancer
F. Anthony Greco et al.
LUNG CANCER (2008)
Directing cancer cells to self-destruct with pro-apoptotic receptor agonists
Avi Ashkenazi
NATURE REVIEWS DRUG DISCOVERY (2008)
Bcl-2 family proteins and cancer
K. W. Yip et al.
ONCOGENE (2008)
Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Promotes Migration of Human Bone Marrow Multipotent Stromal Cells
Paola Secchiero et al.
STEM CELLS (2008)
The TRAIL apoptotic pathway in cancer onset, progression and therapy
Ricky W. Johnstone et al.
NATURE REVIEWS CANCER (2008)
Trail death receptor-4 expression positively correlates with the tumor grade in breast cancer patients with invasive ductal carcinoma
Ahter D. Sanlioglu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL
Klaus W. Wagner et al.
NATURE MEDICINE (2007)
Who should be sent for genetic testing in hereditary colorectal cancer syndromes?
Henry T. Lynch et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Lipid rafts and nonrafts mediate tumor necrosis factor-related apoptosis-inducing ligand-induced apoptotic and nonapoptotic signals in non-small cell lung carcinoma cells
Jin H. Song et al.
CANCER RESEARCH (2007)
A phase I pharmacokinetic and pharmacodynamic study of AMG 479, a fully human monoclonal antibody against insulin-like growth factor type 1 receptor (IGF-1R), in advanced solid tumors
A. W. Tolcher et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Receptor-mediated endocytosis is not required for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis
Susan L. Kohlhaas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Phase I pharmacokinetic and biologic correlative study of mapatumumab, a fully human monoclonal antibody with agonist activity to tumor necrosis factor-related apoptosis-inducing ligand receptor-1
Anthony W. Tolcher et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
TRAIL/bortezomib cotreatment is potentially hepatotoxic but induces cancer-specific apoptosis within a therapeutic window
Ronald Koschny et al.
HEPATOLOGY (2007)
TRAIL induces receptor-interacting protein 1-dependent and caspase-dependent necrosis-like cell death under acidic extracellular conditions
Olivier Meurette et al.
CANCER RESEARCH (2007)
Distinct signaling pathways in TRAIL- versus tumor necrosis factor-induced apoptosis
Zhaoyu Jin et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2
Delphine Merino et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Flavopiridol induces cellular FLICE-inhibitory protein degradation by the proteasome and promotes TRAIL-induced early signaling and apoptosis in breast tumor cells
Carmen Palacios et al.
CANCER RESEARCH (2006)
Nitrosylcobalamin promotes cell death via S nitrosylation of Apo2L/TRAIL receptor DR4
Zhuo Tang et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Trail induces cell migration and invasion in apoptosis-resistant cholangiocarcinoma cells
N Ishimura et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Inhibition of DNA methylation sensitizes glioblastoma for tumor necrosis factor-related apoptosis-inducing ligand-mediated destruction
A Eramo et al.
CANCER RESEARCH (2005)
Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand
E Varfolomeev et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Cutting edge: TRAIL deficiency accelerates hematological malignancies
N Zerafa et al.
JOURNAL OF IMMUNOLOGY (2005)
Selective knockdown of the long variant of cellular FLICE inhibitory protein augments death receptor-mediated caspase-8 activation and apoptosis
DA Sharp et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
c-FLIPR, a new regulator of death receptor-induced apoptosis
A Golks et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Loss of TRAIL-R does not affect thymic or intestinal tumor development in p53 and adenomatous polyposis coli mutant mice
HH Yue et al.
CELL DEATH AND DIFFERENTIATION (2005)
Induction of tumor-specific T cell immunity by anti-DR5 antibody therapy
K Takeda et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Cell death: Critical control points
NN Danial et al.
CELL (2004)
TRAIL-R as a negative regulator of innate immune cell responses
GE Diehl et al.
IMMUNITY (2004)
TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-κB
H Ehrhardt et al.
ONCOGENE (2003)
Overview: apoptotic signaling pathways in the immune system
DR Green
IMMUNOLOGICAL REVIEWS (2003)
Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-/- mice
SE Lamhamedi-Cherradi et al.
NATURE IMMUNOLOGY (2003)
The long form of FLIP is an activator of caspase-8 at the fas death-inducing signaling complex
O Micheau et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Mechanisms of resistance to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukaemia
M MacFarlane et al.
ONCOGENE (2002)
Tumor necrosis factor-related apoptosis-inducing ligand-induced death-inducing signaling complex and its modulation by c-FLIP and PED/PEA-15 in glioma cells
C Xiao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice
E Cretney et al.
JOURNAL OF IMMUNOLOGY (2002)
Tumor-cell resistance to death receptor-induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax
H LeBlanc et al.
NATURE MEDICINE (2002)
The molecular architecture of the TNF superfamily
JL Bodmer et al.
TRENDS IN BIOCHEMICAL SCIENCES (2002)
Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity
K Ichikawa et al.
NATURE MEDICINE (2001)
Characterization of the human FLICE-inhibitory protein locus and comparison of the anti-apoptotic activity of four different FLIP isoforms
M Djerbi et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2001)
Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions
D Lawrence et al.
NATURE MEDICINE (2001)
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon γ-dependent natural killer cell protection from tumor metastasis
MJ Smyth et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
The TNF and TNF receptor superfamilies: Integrating mammalian biology
RM Locksley et al.
CELL (2001)
Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells
K Takeda et al.
NATURE MEDICINE (2001)
A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling
FKM Chan et al.
SCIENCE (2000)
FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2
MR Sprick et al.
IMMUNITY (2000)
Coordinated regulation of two TRAIL-R2/KILLER/DR5 mRNA isoforms by DNA damaging agents, serum and 17β-estradiol in human breast cancer cells
TTY Wang et al.
BREAST CANCER RESEARCH AND TREATMENT (2000)
Mitochondrial control of cell death
G Kroemer et al.
NATURE MEDICINE (2000)
分享论文
